Class information for: |
Basic class information |
| ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
|---|---|---|---|
| 32398 | 109 | 37.7 | 92% |
Classes in level above (level 2) |
| ID, lev. above |
Publications | Label for level above |
|---|---|---|
| 222 | 19941 | LYMPHANGIOGENESIS//ANGIOGENESIS//ENDOSTATIN |
Terms with highest relevance score |
| Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|---|
| 1 | MGDC | Address | 1 | 100% | 2% | 2 |
| 2 | VERRUCARIN A | Author keyword | 1 | 24% | 4% | 4 |
| 3 | RADIAT TUMOR PHYSIOL | Address | 1 | 19% | 4% | 4 |
| 4 | CHORIODAL NEOVASCULARIZATION | Author keyword | 1 | 50% | 1% | 1 |
| 5 | COMPENSATORY GENE EXPRESSION | Author keyword | 1 | 50% | 1% | 1 |
| 6 | INTERNAL MED PHARMACOL MED CHEM | Address | 1 | 50% | 1% | 1 |
| 7 | PROTEINS OF THE BCL 2 FAMILY | Author keyword | 1 | 50% | 1% | 1 |
| 8 | VET ADM ANN ARBOR | Address | 1 | 50% | 1% | 1 |
| 9 | HYALOID VASCULATURE | Author keyword | 1 | 29% | 2% | 2 |
| 10 | HDMF | Author keyword | 0 | 33% | 1% | 1 |
Web of Science journal categories |
Author Key Words |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
|---|---|---|---|---|---|---|---|
| 1 | VERRUCARIN A | 1 | 24% | 4% | 4 | Search VERRUCARIN+A | Search VERRUCARIN+A |
| 2 | CHORIODAL NEOVASCULARIZATION | 1 | 50% | 1% | 1 | Search CHORIODAL+NEOVASCULARIZATION | Search CHORIODAL+NEOVASCULARIZATION |
| 3 | COMPENSATORY GENE EXPRESSION | 1 | 50% | 1% | 1 | Search COMPENSATORY+GENE+EXPRESSION | Search COMPENSATORY+GENE+EXPRESSION |
| 4 | PROTEINS OF THE BCL 2 FAMILY | 1 | 50% | 1% | 1 | Search PROTEINS+OF+THE+BCL+2+FAMILY | Search PROTEINS+OF+THE+BCL+2+FAMILY |
| 5 | HYALOID VASCULATURE | 1 | 29% | 2% | 2 | Search HYALOID+VASCULATURE | Search HYALOID+VASCULATURE |
| 6 | HDMF | 0 | 33% | 1% | 1 | Search HDMF | Search HDMF |
| 7 | CAPILLARY MORPHOGENESIS | 0 | 11% | 3% | 3 | Search CAPILLARY+MORPHOGENESIS | Search CAPILLARY+MORPHOGENESIS |
| 8 | MOLECULAR TARGETED CANCER THERAPY | 0 | 25% | 1% | 1 | Search MOLECULAR+TARGETED+CANCER+THERAPY | Search MOLECULAR+TARGETED+CANCER+THERAPY |
| 9 | PERIPHILIN | 0 | 25% | 1% | 1 | Search PERIPHILIN | Search PERIPHILIN |
| 10 | BH DOMAIN | 0 | 20% | 1% | 1 | Search BH+DOMAIN | Search BH+DOMAIN |
Key Words Plus |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | BCL 2 MICE | 3 | 100% | 3% | 3 |
| 2 | ARTIFICIAL DEATH SWITCHES | 1 | 18% | 4% | 4 |
| 3 | CANCER STEMNESS | 1 | 50% | 1% | 1 |
| 4 | CR PERIPHILIN | 1 | 50% | 1% | 1 |
| 5 | TRANSIENT ADAPTATION | 0 | 15% | 3% | 3 |
| 6 | PTEN GENE THERAPY | 0 | 33% | 1% | 1 |
| 7 | MEDIATED VESSEL OBLITERATION | 0 | 25% | 1% | 1 |
| 8 | MOUSE METANEPHROS | 0 | 25% | 1% | 1 |
| 9 | VIVO ANGIOGENESIS | 0 | 25% | 1% | 1 |
| 10 | CYSTIC KIDNEYS | 0 | 17% | 1% | 1 |
Journals |
Reviews |
| Title | Publ. year | Cit. | Active references | % act. ref. to same field |
|---|---|---|---|---|
| Role of angiogenesis and angiogenic factors in colorectal cancer | 2009 | 2 | 61 | 7% |
| What do oncogenic mutations have to do with angiogenesis/vascular dependence of tumors? | 2002 | 72 | 31 | 3% |
| Angiogenesis and the role of epigenetics in metastasis | 2003 | 16 | 144 | 1% |
Address terms |
| Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | MGDC | 1 | 100% | 1.8% | 2 |
| 2 | RADIAT TUMOR PHYSIOL | 1 | 19% | 3.7% | 4 |
| 3 | INTERNAL MED PHARMACOL MED CHEM | 1 | 50% | 0.9% | 1 |
| 4 | VET ADM ANN ARBOR | 1 | 50% | 0.9% | 1 |
| 5 | ROYAL SURG IRELAND SURG | 0 | 33% | 0.9% | 1 |
| 6 | UMRS 728 | 0 | 25% | 0.9% | 1 |
| 7 | CNR MOL BIOL | 0 | 20% | 0.9% | 1 |
| 8 | PROSTATE CANC TRANSLAT WORKING GRP | 0 | 20% | 0.9% | 1 |
| 9 | BRAIN KOREA 21 PROGRAM | 0 | 17% | 0.9% | 1 |
| 10 | RADIOSENESCENCE | 0 | 17% | 0.9% | 1 |
Related classes at same level (level 1) |
| Rank | Relatedness score | Related classes |
|---|---|---|
| 1 | 0.0000145749 | BCL 2//BCL 2 PROTEIN//BCL X |
| 2 | 0.0000122825 | MCL 1//ABT 737//BCL 2 FAMILY |
| 3 | 0.0000113195 | HUMAN MALIGNANT GLIOMAS//MOL EXPT RADIOL//RADGENOM GRP |
| 4 | 0.0000085190 | METRONOMIC CHEMOTHERAPY//METRONOMIC//LOW DOSE METRONOMIC CHEMOTHERAPY |
| 5 | 0.0000080282 | ALTERNOL//INTENSIVE CARE EQUIPMENT//SEKT NEUROPSYCHOL |
| 6 | 0.0000076473 | ENDOCAN//ESM 1//ENDOTHELIAL CELL SPECIFIC MOLECULE 1 |
| 7 | 0.0000073274 | CLIN BIOMARKERS//MITOCHONDRIAL APOPTOSIS SIGNALING//INTESTINAL OXIDATIVE STRESS |
| 8 | 0.0000071451 | DORSAL SKINFOLD CHAMBER//ABORAT PARTNER LARGE BONE DEFECT HEALING//INOSCULATION |
| 9 | 0.0000068889 | MITHRAMYCIN//AUREOLIC ACID//TOLFENAMIC ACID |
| 10 | 0.0000065864 | FLT 1//VEGF RECEPTORS//VEGF165B |